Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-020877

Chief Executive Officer sold 15,000 shares at an average $157.04 ($2,355,569)

  • Chief Executive Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Saxonov Serge · Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-12 Exercise or conversion : show line 1 in the form +5,209 $5.04 $26,253 885,677 D
2021-03-12 Exercise or conversion : show line 2 in the form +9,791 $11.48 $112,401 895,468 D
2021-03-12 Sale : show line 3 in the form −1,500 $154.37 $231,551 893,968 D
2021-03-12 Sale : show line 4 in the form −2,904 $155.35 $451,147 891,064 D
2021-03-12 Sale : show line 5 in the form −3,105 $156.35 $485,463 887,959 D
2021-03-12 Sale : show line 6 in the form −2,384 $157.42 $375,285 885,575 D
2021-03-12 Sale : show line 7 in the form −1,933 $158.49 $306,355 883,642 D
2021-03-12 Sale : show line 8 in the form −3,174 $159.35 $505,768 880,468 D
Open-market sales · 15,000 sh · avg $157.04 · $2,355,569

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-12 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −5,209 $5.04 2028-11-02 5,209 100,198 D
2021-03-12 Exercise or conversion : show line 10 in the form Stock Option (right to buy) −9,791 $11.48 2029-05-10 9,791 116,880 D
Loading xslF345X03/doc4.xml…